Oncolytic viruses as immunotherapy: progress and remaining challenges
Laure Aurelian Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, USA Abstract: Oncolytic viruses (OVs) comprise an emerging cancer therapeutic modality whose activity involves both direct tumor cell lysis and the induction of immunogenic cell death (ICD...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-05-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/oncolytic-viruses-as-immunotherapy-progress-and-remaining-challenges-peer-reviewed-article-OTT |